Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CCL21 modulators(C-C motif chemokine ligand 21 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | AU | 19 Sep 2024 | |
Lipid Metabolism, Inborn Errors | Preclinical | AU | 19 Sep 2024 | |
Nervous System Diseases | Preclinical | AU | 19 Sep 2024 |